McClarren Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Buy
627
+5
+0.8% +$1.71K 0.12% 80
2026
Q1
$219K Buy
622
+295
+90% +$105K 0.13% 74
2025
Q4
$202K Buy
+327
New +$104K 0.12% 77
2025
Q2
Sell
-608
Closed -$189K 91
2025
Q1
$189K Buy
+608
New +$180K 0.12% 74
2024
Q4
Sell
-618
Closed -$199 204
2024
Q3
$199 Buy
618
+306
+98% +$100K 0.03% 73
2024
Q2
$191K Sell
312
-314
-50% -$92.2K 0.13% 74
2024
Q1
$178K Buy
626
+6
+1% +$1.76K 0.13% 75
2023
Q4
$179K Buy
620
+5
+0.8% +$1.36K 0.14% 73
2023
Q3
$165K Hold
615
0.14% 73
2023
Q2
$136K Sell
615
-18
-3% -$4.18K 0.11% 85
2023
Q1
$153K Buy
633
+1
+0.2% +$245 0.14% 80
2022
Q4
$166K Sell
632
-31
-5% -$8.31K 0.16% 72
2022
Q3
$149K Buy
+663
New +$161K 0.15% 71
2022
Q2
Sell
-668
Closed -$161K 46
2022
Q1
$161K Buy
668
+4
+0.6% +$919 0.12% 69
2021
Q4
$150K Buy
+664
New +$140K 0.1% 74

Other funds holding AMGN

McClarren Financial Advisors's AMGN Position: Q2 2026 in Review

McClarren Financial Advisors increased its Amgen (AMGN) stake by 0.8% in Q2 2026, buying an estimated $1.71K and bringing the position to 627 shares worth $227K. The position accounts for 0.12% of the portfolio, ranked #80.

McClarren Financial Advisors first reported a position in AMGN in Q4 2021 and has held it in 15 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • McClarren Financial Advisors held 627 shares of Amgen worth $227K as of Q2 2026.
  • McClarren Financial Advisors bought 5 Amgen shares in Q2 2026, an estimated $1.71K.
  • Amgen made up 0.12% of McClarren Financial Advisors's portfolio in Q2 2026, its #80 holding.
  • McClarren Financial Advisors first reported a position in Amgen in Q4 2021 and has held it in 15 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on McClarren Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.